Invesco Ltd.

Position in NBIX — Neurocrine Biosciences Inc

CIK 914208 Atlanta, GA

Back to NBIX Full portfolio

Position in NBIX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$46,900,621

-$1,806,776 QoQ

Shares Held

356,009

+3.7% QoQ

Ownership

0.354%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 86.11973292810013.ToString("F0")% None 13.880267071899869.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Invesco Ltd. holds $1,834,470,034 across 45 Drug Manufacturers - Specialty & Generic names. NBIX ranks #9 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,540,968	$418,577,820
2	UTHR	UNITED THERAPEUTICS Corp	608,367	$360,749,459
3	VTRS	Viatris Inc	21,968,657	$296,796,550
4	ELAN	Elanco Animal Health Inc	8,141,172	$194,818,243
5	TEVA	Teva Pharmaceutical Industries Ltd	3,253,233	$97,987,373
6	COLL	Collegium Pharmaceutical, Inc	1,591,909	$52,644,427
7	PRGO	PERRIGO Co plc	4,711,783	$50,604,546
8	INDV	Indivior Pharmaceuticals, Inc.	1,561,763	$47,602,534

All Filings in NBIX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$46,900,621	356,009	+3.7%	Shares	Defined	2026-05-12
2025-12-31	$48,707,397	343,421	+6.1%	Shares	Defined	2026-02-19
2025-09-30	$45,428,507	323,611	+11.9%	Shares	Defined	2025-11-13
2025-06-30	$36,355,199	289,245	-49.0%	Shares	Defined	2025-08-13
2025-03-31	$62,745,587	567,320	-40.3%	Shares	Defined	2025-05-12
2024-12-31	$129,608,385	949,512	+8.6%	Shares	Defined	2025-02-13
2024-09-30	$100,778,896	874,665	-30.5%	Shares	Defined	2024-11-12
2024-06-30	$173,203,172	1,258,104	+10.7%	Shares	Defined	2024-08-13
2024-03-31	$156,807,036	1,136,942	+68.7%	Shares	Defined	2024-05-14
2023-12-31	$88,780,936	673,808	+74.5%	Shares	Defined	2024-02-13
2023-09-30	$43,437,936	386,115	-31.3%	Shares	Defined	2023-11-13
2023-06-30	$53,030,546	562,360	-2.4%	Shares	Defined	2023-08-11
2023-03-31	$58,330,450	576,274	-59.6%	Shares	Defined	2023-05-12
2022-12-31	$170,474,200	1,427,279	+57.6%	Shares	Defined	2023-02-13
2022-09-30	$96,195,562	905,711	+235.1%	Shares	Defined	2022-11-14
2022-06-30	$26,350,497	270,317	+7.3%	Shares	Defined	2022-08-15
2022-03-31	$23,612,342	251,865	-10.4%	Shares	Defined	2022-05-16
2021-12-31	$23,942,819	281,118	-14.2%	Shares	Defined	2022-02-14
2021-09-30	$31,440,351	327,811	-70.0%	Shares	Defined	2021-11-15
2021-06-30	$106,458,249	1,093,899	+0.6%	Shares	Defined	2021-08-17
2021-03-31	$105,746,244	1,087,365	+0.4%	Shares	Defined	2021-05-17
2020-12-31	$103,819,063	1,083,141	-37.5%	Shares	Defined	2021-02-16
2020-09-30	$166,690,759	1,733,473	-11.3%	Shares	Defined	2020-11-16
2020-06-30	$238,303,698	1,953,309	+96.5%	Shares	Defined	2020-08-14
2020-03-31	$86,046,449	994,182	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.